Pharmacotherapy of Bipolar Disorders / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$89.96
Used and New from Other Sellers
Used and New from Other Sellers
from $70.05
Usually ships in 1-2 business days
(Save 41%)
Other sellers (Hardcover)
  • All (9) from $70.05   
  • New (7) from $77.26   
  • Used (2) from $70.05   

Overview

Comprehensively, concisely and up-to-date - this text reviews in detail all aspects of the diagnosis and pharmacological treatment of bipolar disorders, one of the most topical issues in psychiatry.

In this manual, rather than presenting treatment algorithms, the authors have chosen to present a synopsis of the literature and knowledge based on daily clinical practice. At the end of each chapter, the important concepts and recommendations are summarized for the reader as a reminder of the key points.

The French version of this book, (published in 2004), received a prize in the category Specialized Medicine at the 3rd international festival of the medical books, Amiens, France. Since this first French edition, the text has now been revised and more than 500 new references have been added, in order to be updated with the rapidly growing literature in the field.

Pharmacotherapy of Bipolar Disorders is an invaluable resource for all psychologists, psychiatrists, interns and residents in psychiatry. It is of interest also for general practitioners, clinicians, nurses and any others who are involved with the management of patients with bipolar disorder.

Read More Show Less

Editorial Reviews

From the Publisher
"This is a comprehensive review of the drug treatments available particularly in European countries. It is up to date and well-written." (Human Psychopharmacology: Clinical and Experimental, December 2008)
Doody's Review Service
Reviewer: Raj Tummala, MD (Wyeth Pharmaceuticals)
Description: This is a translation from the French of the award-winning comprehensive overview of the pharmacological treatments for bipolar disorder. The authors cover the extensive range of agents available for treatment through a summary of the literature, evidence-based medicine and clinical experience.
Purpose: The purpose is to provide a comprehensive review of bipolar psychopharmacotherapy with a special focus on the different phases of bipolar disorder and special populations.
Audience: This book is targeted at anyone dealing with the care of bipolar patients such as residents, students, clinicians, and practitioners.
Features: There has been increased awareness of the prevalence of bipolar disorder over the last decade. In addition, many new pharmaceutical agents have been approved for the treatment of the various aspects of bipolar disorder. Starting with a succinct review of epidemiology, the authors discuss the classification of bipolar disorder based on DSM, ICD, and other sources. The currently available/used pharmacological treatments are detailed, covering all aspects of pharmacology including a "practical aspects" section. Treatments like lithium and valproate, newer treatments such as lamotrigine and other anticonvulsants along with the second-generation antipsychotics are discussed in detail. Each chapter has a nice summary section with key points from the chapter. Information is augmented with bullet points, easy to read graphs, tables, and charts. The topics are extensively referenced with information from clinical trials and other evidence-based medicine as well as expert consensus. Deserving special mention are the sections on medications that induce the various phases of bipolar disorder. The authors cover the treatment of the various phases/types of bipolar disorder, both in the general and special populations.
Assessment: As with many translations, the phrasing seems awkward at times, but overall this is a nicely done translation and the book covers all of aspects of the pharmacological treatment of bipolar disorder. Overall, it is a practical, user-friendly overview/reference of the pharmacological treatment of bipolar disorder.
Read More Show Less

Product Details

  • ISBN-13: 9780470058237
  • Publisher: Wiley
  • Publication date: 6/11/2007
  • Edition description: New Edition
  • Edition number: 1
  • Pages: 296
  • Product dimensions: 6.95 (w) x 9.90 (h) x 0.94 (d)

Meet the Author

Jean-Michel Aubry is a psychiatrist and psychotherapist. He is privat docent at the Medical School of the University of Geneva where he teaches Neurosciences and Psychiatry. As head of a specialised programme for bipolar disorders at the Department of Psychiatry of the Geneva University Hospital, Dr Aubry’s research interests include the pharmacologicala and psychosocial treatments of bipolar disorders and more specifically, relapse prevention.

François Ferrero is psychiatrist, psychotherapist, professor of psychiatry and chair of the Department of Psychiatry of the University of Geneva. His research in the domain of bipolar disorders aims to better specify the epidemiology and the links with genetics and the environment in order to develop and evaluate ever more effective therapeutic and preventive approaches.

Nicolas Schaad is the pharmacist in charge of the pharmacy la Côte that serves the hospital network of the Geneva-Lausanne region. Within this structure, he has developed a clinical pharmacy service. He is privat docent in the pharmacy section, and he also teaches in the Department of  Fundamental Neurosciences at the University of Geneva. For the past few years, his research interests have been oriented towards a psychopharmacology applied to psychiatric disorders.

Mark   S. Bauer   is Professor in the Department of Psychiatry and Human Behavior at Brown University and on staff in the Mental Health service of the Department of Veterans Affairs Medical Center in Providence, Rhode Island, USA.  He has been recognized with awards for his research, clinical expertise and teaching skills. He served for 11 years on the Scientific Advisory Board for the Depression and Bipolar Support Alliance and has been named Exemplary Psychiatrist by the National Alliance for the Mentally Ill.

Read More Show Less

Table of Contents

Foreword.

Preface by N. Sartorius.

Chapter 1 Epidemiology of bipolar disorders.

Contribution of epidemiological studies to the diagnosis.

The definition of bipolar disorder (BD).

Demographic and social variables.

A few important historical epidemiological studies.

Other studies carried out in the general population.

Key points.

References.

Chapter 2 Classification of bipolar disorders.

Mania.

Hypomania.

Cyclothymia.

Hyperthymia and hyperthymic temperament.

Bipolar depression.

Depressive mixed states (DMX).

Mixed mania.

Bipolar I disorder.

Bipolar II disorder.

Bipolar III disorder (Pharmacological hypomania).

Bipolar IV disorder.

Rapid cycling.

Minor bipolar disorders.

Some open questions.

Key points.

References.

Chapter 3 How to define a mood stabilizer.

The definitions of a mood stabilizer.

Key points.

References.

Chapter 4 Lithium.

History.

Mode of action.

Clinical studies.

Principal indications.

Pharmacokinetic and metabolism.

Interactions.

Medications that can be administered with lithium.

Side effects.

Practical aspects.

Key points.

References.

Chapter 5 Carbamazepine.

History.

Mode of action.

Clinical studies.

Principal indications.

Pharmacokinetic and metabolism.

Interactions.

Side effects.

Practical aspects.

Key points.

References.

Chapter 6 Lamotrigine.

History.

Mode of action.

Clinical studies.

Principal indications.

Pharmacokinetic and metabolism.

Interactions.

Side effects.

Practical aspects.

Key points.

References.

Chapter 7 Topiramate.

History.

Mode of action.

Clinical studies.

Pharmacokinetic and metabolism.

Interactions.

Side effects.

Practical aspects.

Key points.

References.

Chapter 8 Valproic acid.

History.

Mode of action.

Clinical studies.

Principal indications.

Pharmacokinetic and metabolism.

Interactions.

Side effects.

Practical aspects.

Key points.

References.

Chapter 9 The role of atypical or second generation antipsychotics.

What is an atypical antipsychotic?

For the pharmacologist.

For the clinician.

Side effects.

Effects on memorization processes.

Interactions.

Antipsychotics and bipolar disorder.

Atypical or second generation antipsychotics and the treatment of mania.

Atypical or second generation antipsychotics and the treatment of depression.

Atypical or second generation antipsychotics and maintenance treatment.

Key points.

References.

Chapter 10 Other medications used for bipolar disorders.

Gabapentin.

Oxcarbazepine.

Calcium channel blockers.

Omega-3 fatty acids.

Key points.

References.

Chapter 11 Medications that may potentially induce a depressive state.

References.

Chapter 12 Medications that may potentially induce a (hypo)manic syndrome.

References.

Chapter 13 Maintenance treatment: when should be a long term treatment introduced.

Initiating treatment during a manic or mixed episode.

Initiating treatment during a depressive episode.

Initiating treatment during an euthymic period.

Choosing a maintenance treatment.

Key points.

References.

Chapter 14 Treatment of the depressive phases of bipolar disorders.

Antidepressants.

Risk of manic switch.

Duration of antidepressant treatment.

Antidepressant discontinuation syndromes.

Mood stabilizers.

Antipsychotics.

Depression in the absence of a mood stabilizer.

Depressive relapse despite a mood stabilizing treatment.

Depressive relapse despite a combined treatment.

Resistant depression.

Key points.

References.

Chapter 15 Treatment of Bipolar II disorder.

Treatment of bipolar II depression.

Treatment of hypomania.

Long-term treatment.

Key points.

References.

Chapter 16 Treatment of manic phases.

Different sub-types of mania.

Treatment of hypomania.

Treatment of euphoric mania.

Treatment of dysphoric mania.

Treatment of mania with psychotic symptoms.

Treatment of mania in patients with rapid cycling.

Other psychotropic drugs in evaluation for the treatment of mania.

Other treatments.

Key points.

References.

Chapter 17 Treatment of rapid cycling.

Lithium.

Valproate.

Carbamazepine and oxcarbazepine.

Lamotrigine.

Other anticonvulsants.

Clozapine and other atypical antipsychotics.

Thyroid hormones.

Key points.

References.

Chapter 18 Treatment of mixed states.

Lithium.

Valproate.

Carbamazepine.

Other anticonvulsants.

Antidepressants.

Antipsychotics.

Key points.

References.

Chapter 19 Combination treatments.

Combination treatments for mania.

Combination treatments for depression.

Combination treatments for relapse prevention.

Treatment combinations and side effects.

Treatment combinations and interactions.

Key points.

References.

Chapter 20 Bipolar disorders, pregnancy and breastfeeding.

Pregnancy and the risk of relapse.

Risk of relapse during the postpartum period.

Psychotropic medication and the risks for the fetus.

Key points.

Breastfeeding.

Key points.

References.

Chapter 21 Bipolar disorders in children and adolescents.

Clinical characteristics and differential diagnosis.

Pharmacological treatments.

Lithium.

Valproate.

Carbamazepine.

Other treatments.

Juvenile bipolar disorder and relapse prevention treatment.

Key points.

References.

Chapter 22 Bipolar disorders in geriatric patients.

Epidemiology.

Clinical presentation and diagnosis.

Secondary mania and comorbidity with certain neurological disorders.

Disinhibition syndromes.

Bipolar III disorder.

Pharmacological treatments.

Key points.

References.

Appendix.

1. Diagnostic criteria ICM 10.

2. Diagnostic criteria DSM IV.

3. FDA approved medications for the treatment of bipolar disorders.

4. Major guidelines for bipolar disorders.

5. Trade names of selected drugs used in bipolar disorders.

List of abbreviations.

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)